![Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41575-020-0310-z/MediaObjects/41575_2020_310_Fig2_HTML.png)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![DrummerIX on X: "[Trainer] Dying Light [+28][23.03.2022] - update for 1.48.2 game version https://t.co/LUYS954WVe https://t.co/5k0l6A485G" / X DrummerIX on X: "[Trainer] Dying Light [+28][23.03.2022] - update for 1.48.2 game version https://t.co/LUYS954WVe https://t.co/5k0l6A485G" / X](https://pbs.twimg.com/media/FOkE8eKXsAIXIAu.jpg)
DrummerIX on X: "[Trainer] Dying Light [+28][23.03.2022] - update for 1.48.2 game version https://t.co/LUYS954WVe https://t.co/5k0l6A485G" / X
![PDF) Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities | Monique Elseviers and Patricia Van Der Niepen - Academia.edu PDF) Interim results of the SHARF4 study: outcome of acute renal failure with different treatment modalities | Monique Elseviers and Patricia Van Der Niepen - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43777335/mini_magick20220704-11983-slinyk.png?1656919109)